Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
The Persian Cohort: Providing the Evidence Needed for Healthcare Reform



Eghtesad S1, 2 ; Mohammadi Z1, 2 ; Shayanrad A2 ; Faramarzi E3 ; Joukar F4 ; Hamzeh B5 ; Farjam M6 ; Sakhvidi MJZ7 ; Mirimonjar M8 ; Moosazadeh M9 ; Hakimi H10 ; Kazerooni SR11 ; Cheraghian B12 ; Ahmadi A13 Show All Authors
Authors
  1. Eghtesad S1, 2
  2. Mohammadi Z1, 2
  3. Shayanrad A2
  4. Faramarzi E3
  5. Joukar F4
  6. Hamzeh B5
  7. Farjam M6
  8. Sakhvidi MJZ7
  9. Mirimonjar M8
  10. Moosazadeh M9
  11. Hakimi H10
  12. Kazerooni SR11
  13. Cheraghian B12
  14. Ahmadi A13
  15. Nejatizadeh A14
  16. Mohebbi I15
  17. Pourfarzi F16
  18. Roozafzai F2
  19. Motamedgorji N2
  20. Montazeri SA2
  21. Masoudi S17
  22. Aminesmaeili M18
  23. Danaie N19
  24. Mirhafez SR20
  25. Hashemi H21
  26. Poustchi H2
  27. Malekzadeh R1, 17

Source: Archives of Iranian Medicine Published:2017

Abstract

In the past, communicable diseases caused the highest mortality in Iran. Improvements in socioeconomic status and living standards including access to safe drinking water, along with the inception of Health Houses in the 1980s, have changed disease patterns, decreasing the spread of and deaths from infectious and communicable diseases. The incidence and prevalence of non-communicable diseases (NCD), however, have now increased in Iran, accounting for nearly 80% of deaths and disabilities. Without interventions, NCD are predicted to impose a substantial human and economic burden in the next 2 decades. However, Iran’s health system is not equipped with the necessary policies to combat this growth and must refocus and reform. Therefore, in the year 2013, the Ministry of Health and Medical Education funded a well-designed nationwide cohort study—Prospective Epidemiological Research Studies in IrAN (PERSIAN)—in order to assess the burden of NCD and investigate the risk factors associated with them in the different ethnicities and geographical areas of Iran. The PERSIAN Cohort, which aims to include 200 000 participants, has 4 components: Adult (main), Birth, Youth and Elderly, which are being carried out in 22 different regions of Iran. Having an enormous dataset along with a biobank of blood, urine, hair and nail samples, the PERSIAN Cohort will serve as an important infrastructure for future implementation research and will provide the evidence needed for new healthcare policies in order to better control, manage and prevent NCD. © 2017 The Author(s).
Other Related Docs
5. The Persian Guilan Cohort Study (Pgcs), Archives of Iranian Medicine (2019)
13. Incidence, Early Case Fatality and Determinants of Stroke in Iran: Golestan Cohort Study, Journal of Stroke and Cerebrovascular Diseases (2022)